The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Microbial systems are a black box. We created Microbial INtelligence Explorer to “MINE” their secrets• Microbiotica Raises $48 Million Series C to Advance Pipeline into Phase 2 Clinical Development• Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination•

Category: Infectious Disease & AMR

A new simple and effective tool that recommends the best possible phage cocktail for a given patient
Infectious Disease & AMR

A new simple and effective tool that recommends the best possible phage cocktail for a given patient

NOV 28, 2024
Florey Biosciences spins out of Harvard Wyss Institute to develop a medical food aimed at managing impacts of antibiotic use
Finance

Florey Biosciences spins out of Harvard Wyss Institute to develop a medical food aimed at managing impacts of antibiotic use

OCT 1, 2024
Phage lysin compound HY-133: Start of clinical phase I “first-in-human” study to eliminate Staphylococcus aureus
Clinical & Manufacturing

Phage lysin compound HY-133: Start of clinical phase I “first-in-human” study to eliminate Staphylococcus aureus

SEP 1, 2024
Mining the microbiome: Uncovering new antibiotics inside the human gut
Infectious Disease & AMR

Mining the microbiome: Uncovering new antibiotics inside the human gut

AUG 27, 2024
The Clinical Journey of a Novel LBP for Bacterial Vaginosis Developed by MGH& Biose Industrie.
Editor's Choice

The Clinical Journey of a Novel LBP for Bacterial Vaginosis Developed by MGH& Biose Industrie.

MAY 22, 2024
Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 Study for the Prevention of Recurrent C. diff Infection
Clinical & Manufacturing

Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 Study for the Prevention of Recurrent C. diff Infection

MAY 22, 2024
A virus could help save billions of gallons of wastewater produced by fracking
Infectious Disease & AMR

A virus could help save billions of gallons of wastewater produced by fracking

MAY 8, 2024
SNIPR Biome receives funding from CARB-X for advancement of SNIPR001 into clinical trials in haematological cancer patients
Clinical & Manufacturing

SNIPR Biome receives funding from CARB-X for advancement of SNIPR001 into clinical trials in haematological cancer patients

APR 22, 2024
New enzymatic cocktail can kill tuberculosis-causing mycobacteria
Infectious Disease & AMR

New enzymatic cocktail can kill tuberculosis-causing mycobacteria

APR 15, 2024
BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50M Financing
Finance

BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50M Financing

MAR 7, 2024
EIC selects Gedea Biotech for €2.5M grant funding for development of their antibiotic free treatment for vaginal infections
Finance

EIC selects Gedea Biotech for €2.5M grant funding for development of their antibiotic free treatment for vaginal infections

MAR 1, 2024